Cheryl Guttman Krader
Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.
USPSTF guide’s impact: The jury is still out
With several years now passing since the USPSTF issued its grade D recommendation discouraging PSA-based prostate cancer screening, researchers are reporting conflicting findings on its impact on clinical practice.
Long-term TRT study refutes concerns about prostate safety
Long-term TRT study refutes concerns about prostate safety
A study of more than 300 men sheds new light on the prostate safety of testosterone replacement therapy.
Compliance with PCa quality measures not tied to outcomes
Compliance with PCa quality measures not tied to outcomes
A study of patient outcomes 1 year after localized prostate cancer care seems to indicate that the answer is “no.”
Extended antimicrobial prophylaxis raises C. diff risk
Whereas best practice policy states that antimicrobial prophylaxis for urologic procedures should be discontinued within 24 hours, extended regimens are common among patients undergoing surgery for urologic cancer and putting them at risk for hospital-acquired Clostridium difficile colitis, say researchers from the University of Washington, Seattle.
Study: 'Optical biomarkers' may have utility in RCC
A novel optical imaging technology is showing promise as a potential diagnostic tool for renal cell carcinoma.
Survey: More retinal surgeons using primary vitrectomy, microincisional technology
Surveys examining retinal surgeon-practice patterns for retinal detachment show preferences differ regionally.
MRI may add value in monitoring men on surveillance
Multiparametric MRI of the prostate with subsequent targeted biopsy shows promise for improving the identification of men on active surveillance for low-risk prostate cancer who require definitive treatment, according to researchers from the Vancouver Prostate Centre, Vancouver, BC.
Laser-assisted procedure brings ease, precision, safety to deep sclerectomy
CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.
Brinzolamide/brimonidine demonstrates broad efficacy in subgroup analyses
The protocols for the pivotal trials establishing the efficacy of the brinzolamide 1%/brimonidine 0.2% fixed combination included pre-planned analyses of subgroups defined by IOP and demographic characteristics.
Predicting glaucoma onset: AIG identifies prognostic value for FD-OCT
Analyses of data from the Advanced Imaging for Glaucoma Study showed many Fourier-domain optical coherence tomography parameters were significant risk factors for glaucoma onset in eyes that were glaucoma suspect or had pre-perimetric glaucoma.